FDA Clearance Tracker · P040044-S045
MYNX VASCULAR CLOSURE DEVICE
Last checked: Nov 20, 2026Latest source record: Jul 22, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Jul 22, 2013
Approved
Time to decision
250 days
Received Nov 14, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040044-S045
- Device name
- MYNX VASCULAR CLOSURE DEVICE
- Applicant
- Cordis US Corporation
- Applicant location
- Miami Lakes, FL
- Received
- Nov 14, 2012
- Decided
- Jul 22, 2013
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P040044
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED IN SANTA CLARA, CALIFORNIA.
Source documents
Other decisions for Cordis US Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PRECISE PRO RX Transcarotid Stent SystemPMA supplement
P030047-S049 · Decided Apr 4, 2025 · 185 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
P040044-S097 · Decided Jun 27, 2024 · 210 days after receipt · Panel Track
Device type: Device, hemostasis, vascular (MGB) · Cardiology
P150002 · Decided Nov 27, 2018 · 1,412 days after receipt
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.